ARTICLE | Company News
Novartis, Dr. Reddy's Labs in insulin deal
May 29, 2001 7:00 AM UTC
Dr. Reddy's Laboratories (RDY) granted Novartis (NVS; SWX:NOVN) exclusive worldwide development and marketing rights to its DR 4158 insulin sensitizer to treat Type II diabetes. RDY will receive up to...